News

Currently, Lopez is the chief operating officer of Fero and the managing director of Pharmaroth Latin America. Lopez will be responsible for developing and executing the company’s global

The study aims to investigate the safety and efficacy of DRL-17822 in patients with type-II dyslipidemia. In the study, three doses (50, 150 & 300mg) of DRL-17822 given

Cortegra Group is a US based producer of pharmaceutical leaflets and labels and provides packaging and labeling services to the healthcare and related industries. Chesapeake CEO Mike Cheetham

Currently under development using the personalized healthcare (PHC) approach by Roche, MetMAb is indicated as a treatment for non-small cell lung cancer (NSCLC) and lebrikizumab for bronchial asthma.

Pfizer will use the new site for its Cardiovascular, Metabolic and Endocrine Disease (CVMED) and Neuroscience Research Units. PharmaTherapeutics R&D head and senior vice president Rod MacKenzie said

The pharma partner has received worldwide rights to the development and commercialization of three antibodies generated by AnaptysBio using the SHM-XEL platform, under the collaboration. AnaptysBio is eligible

KLP and China Botanic aim to add value to all processes, including planting, collection, processing, research and development and production. The cooperation with KLP will allow China Botanic

The results of the trial suggested that the tolerability and efficacy of Crestor seen in Saturn were in line with previous studies and approved product labelling. The results

The allowance further strengthens the Marina’s nucleic acid-peptide drug delivery platform and expands the patent protection for its comprehensive set of nucleic acid delivery technologies. The patent application